TNFSF13 anticorps (AA 1-17)
Aperçu rapide pour TNFSF13 anticorps (AA 1-17) (ABIN296179)
Antigène
Voir toutes TNFSF13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-17
-
Specificité
- A synthetic peptide corresponding to amino acids 1-17 of human APRIL.
-
Purification
- Protein G purified
-
Immunogène
-
Synthetic peptide from human TNFSF13 / APRIL.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IHC, IHC-P (5 μg/mL), WB (2 - 4 μg/mL)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 5 μg/mL. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- avoid freeze thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
-
- TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
-
Autre désignation
- TNFSF13 / APRIL
-
Sujet
-
Name/Gene ID: TNFSF13
Family: TNF
Synonyms: TNFSF13, APRIL, CD256, CD256 antigen, TALL-2, TALL2, ZTNF2, TNF-related death ligand 1, TRDL-1, UNQ383/PRO715 -
ID gène
- 8741
-
UniProt
- O75888
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Antigène
-